Combining targeted antibacterial treatments with chemotherapy can suppress both TRIM and tumor cells, promoting M2-to-M1-like tumor-associated macrophage repolarization and achieving long-term survival in animal models with no recurrence (Wang et al., 2024). This evidence concerns the gene TRAT1 and neoplasm.